# Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

> **NCT05576415** · PHASE1 · COMPLETED · sponsor: **Corxel Pharmaceuticals** · enrollment: 9 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Varenicline Tartrate Nasal Spray

## Key facts

- **NCT ID:** NCT05576415
- **Lead sponsor:** Corxel Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-07
- **Primary completion:** 2023-04-27
- **Final completion:** 2023-04-27
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05576415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05576415, "Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05576415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*